Pamela Stephenson
Vermögen: 1 Mio $ am 31.08.2026
Vermögen: 1 Mio $ am 31.08.2026
Ms. Pamela Stephenson is a Chief Commercial Officer at Disc Medicine, Inc. Ms. Stephenson was previously employed as a Chief Commercial Officer by Albireo Pharma, Inc., an Independent Director by Zynerba Pharmaceuticals, Inc., and a Vice President-Global Market Access & Value by Vertex Pharmaceuticals, Inc. She received her undergraduate degree from Brown University and a graduate degree from Boston University School of Public Health.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,05 % | 22.04.2026 | 18 665 ( 0,05 % ) | 1 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 10.10.2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01.04.2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.03.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen